HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome by Chernock, Rebecca D. et al.
ORIGINAL PAPER
HPV-Related Nonkeratinizing Squamous Cell Carcinoma
of the Oropharynx: Utility of Microscopic Features
in Predicting Patient Outcome
Rebecca D. Chernock Æ Samir K. El-Mofty Æ
Wade L. Thorstad Æ Curtis A. Parvin Æ
James S. Lewis Jr
Received: 6 April 2009/Accepted: 26 June 2009/Published online: 11 July 2009
 Humana 2009
Abstract Human papilloma virus (HPV) is an etiologic
agent in a subset of oropharyngeal squamous cell carci-
nomas (SCCs). The aim of this study was to sub-classify
SCC of the oropharynx based upon histologic features into
nonkeratinizing (NK) SCC, keratinizing (K) SCC, and
hybrid SCC, and determine the frequency of HPV and
patient survival in each group. Patients with oropharyngeal
SCC with a minimum of 2 years of clinical follow-up were
identiﬁed from radiation oncology databases from 1997 to
2004. All patients received either up front surgery with
postoperative radiation or deﬁnitive radiation based ther-
apy. In situ hybridization (ISH) for high-risk HPV subtypes
and immunohistochemistry for p16, a protein frequently
up-regulated in HPV-associated carcinomas, were per-
formed. Overall and disease-speciﬁc survival were asses-
sed. Of 118 cases, 46.6% were NK SCC, 24.6% K SCC and
28.8% hybrid SCC. NK SCC occurred in slightly younger
patients that were more often male. It more frequently
presented with lymph node metastases and was surgically
resected compared to K SCC. NK SCC was signiﬁcantly
more likely to be HPV and p16 positive than KSCC
(P\0.001) and to have better overall and disease-speciﬁc
survival (P = 0.0002; P = 0.0142, respectively). Hybrid
SCC was also more likely than K SCC to be HPV and p16
positive (P = 0.003; P = 0.002, respectively) and to have
better overall survival (P = 0.0105). Sub-classiﬁcation of
oropharyngeal SCC by histologic type provides useful
clinical information. NK SCC histology strongly predicts
HPV-association and better patient survival compared to K
SCC. Hybrid SCC appears to have an intermediate fre-
quency of HPV-association and patient survival.
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Introduction
Human papillomavirus (HPV) infection is now recognized
as an etiologic agent in a subset of head and neck squamous
cell carcinomas (SCCs) that are clinically and biologically
distinct [1–9]. HPV-related SCC occurs predominantly in
the oropharynx and affects younger patients [3, 7, 10]. The
risk factors are similar to those of HPV-related cervical
SCC and include a high lifetime number of vaginal or oral-
sex partners [9, 11–14]. This is unlike non-HPV related
SCC, which is more commonly linked with heavy tobacco
and alcohol use [14–16]. Importantly, in spite of a tendency
to present at high stage, HPV-related SCC is associated
with better patient survival [1, 4, 7]. Recent evidence
suggests that unique molecular events in HPV-related SCC
may, in fact, underlie their distinct biological behavior
[5, 17–19].
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DOI 10.1007/s12105-009-0126-1Furthermore, El-Mofty et al. [20, 21] have noted that
HPV-related SCC of the oropharynx has unique histologic
features. The tumors tend to be nonkeratinizing squamous
cell carcinomas (NK SCCs). They form sheets, nests and
trabeculae that have pushing borders with little stromal
response. Frequent mitoses and comedo necrosis are
characteristic features. The cells are ovoid to spindle-
shaped with hyperchromatic nuclei that lack prominent
nucleoli and have indistinct cell borders (Fig. 1). These
morphologic features are in contrast to those of non-HPV
related SCC, which is keratinizing and composed of
polygonal cells with abundant, mature cytoplasm, distinct
cell borders and intercellular bridges. The growth pattern of
these tumors is typically inﬁltrative with angulated nests
that have tapered extensions and pronounced stromal des-
moplasia (Fig. 2). Additionally, El-Mofty et al. [22]
described an intermediate or ‘‘hybrid’’ histologic group
with partial squamous maturation that also appears to be
HPV-related (Fig. 3).
Determination of HPV status in oropharyngeal carcino-
mas is becoming recognized as an important consideration
in the management of these tumors and prediction of patient
outcome. A variety of HPV detection methods are currently
used, including PCR, ISH and immunohistochemistry. p16
is a tumor suppressor protein that is also considered to be a
surrogate marker of HPV infection in squamous cell car-
cinomas of the cervix and head and neck [23]. However,
false negatives and false positives are reported with each of
Fig. 1 Histologic features of NK SCC (H&E stained sections). a
Low-power image (9100) showing nest of tumor cells with pushing
borders and comedo-type necrosis. In addition, there is a lack of
stromal desmoplasia around the tumor nests. b High-power image
(9600) showing oval to spindled, hyperchromatic tumor cells that
lack prominent nucleoli and have indistinct cell borders
Fig. 2 Histologic features of K
SCC (H&E stained sections).
a Low-power image (9100)
showing sheets of tumor cells
with keratin pearl formation.
b Low-power image (9200)
showing inﬁltrative nests of
polygonal-shaped tumor cells
with abundant, eosinophilic
(‘‘mature’’) cytoplasm and
distinct cell borders. c Low-
power image (9200) showing
desmoplastic stroma
surrounding tumor nests.
d High-power image (9600)
highlighting intercellular
bridges
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viral mRNA E6 and E7 in fresh tissue is the gold standard
for HPV detection. Using techniques that are applicable
to formalin-ﬁxed parafﬁn-embedded tissue, there is often
a lack of agreement as to what is considered evidence
of pathophysiologically and clinically signiﬁcant HPV
involvement.
Histologic classiﬁcation is simple and relatively
straightforward. It also correlates well with HPV detection
by ISH and p16 immunohistochemistry [20–22]. However,
the use of histologic classiﬁcation in determining HPV-
association has not gained widespread acceptance. This
may be, in part, due to the lack of studies that correlate
histologic features directly with patient outcome.
The aim of this study was threefold: ﬁrst, to sub-classify
oropharyngeal carcinomas into three groups according to
the above mentioned morphologic features: nonkeratinizing
squamous cell carcinoma (NK SCC), keratinizing squa-
mous cell carcinoma (K SCC) and hybrid squamous cell
carcinoma (hybrid SCC); second, to determine HPV status
of the tumors using HR HPV-ISH and p16 immunostaining;
and third, to determine overall and disease-speciﬁc survival
of patients in each histologic sub-group. The use of simple
morphologic features to sub-classify SCC of the oropharynx
is potentially useful, particularly if predictive of patient
outcome.
Materials and Methods
Case Selection and Classiﬁcation
Cases of oropharyngeal SCC were identiﬁed from a
Radiation Oncology head and neck database at Barnes-
Jewish Hospital from 1997 to 2004. This is an IRB
approved combined retrospective/prospective database
with a waiver for retrospective data collection and patient
consent for prospective data collection. Radiation was
either postoperative for patients managed with an up front
surgical approach, or deﬁnitive for patients managed
without surgery. Patients were treated exclusively with
intensity modulated radiation therapy (IMRT) by a single
radiation oncologist (WLT). Patients had a minimum of
2 years of clinical follow-up assessed from the end of
radiation therapy with the exception of 5 patients who were
lost to follow up within 2 years. The mean length of fol-
low-up was 3.3 years (range of 5 months to 8 years). Only
cases with primary and pre-treatment surgical pathology
material available for review were included. The diagnosis
of SCC was conﬁrmed by slide review and all recognized
variants such as verrucous, spindle cell, papillary, adeno-
squamous, undifferentiated, and basaloid squamous cell
carcinomas were excluded. Particular care was taken to
exclude cases of basaloid squamous cell carcinoma, which
is histologically distinct from nonkeratinizing squamous
cell carcinoma. Basaloid squamous cell carcinoma, as
deﬁned by Wain’s criteria, is intimately associated with
keratinizing squamous cell carcinoma, and is composed of
a lobular proliferation of small, crowded cells with scant
cytoplasm and round, hyperchromatic nuclei [24]. In
addition, it has cystic spaces with mucin-like material,
coagulative necrosis and stromal hyalinosis with basement
membrane-like material [22].
The cases were classiﬁed independently by three
reviewers (RDC, SKEM, JSL), prior to HPV testing and
without knowledge of clinical outcome, into the following
three categories based upon histologic features: NK SCC, K
SCC, and those with overlapping features (referred to as
hybrid SCC). NK SCC was deﬁned as forming sheets, nests
or trabeculae with pushing borders, little stromal response,
and having ovoid to spindled, hyperchromatic cells that lack
prominent nucleoli and have indistinct cell borders (Fig. 1).
Comedo-type necrosis and brisk mitotic activity were often
present but were not considered requisite features. While
varying from well to poorly differentiated, K SCC was
deﬁned as entirely composed of mature squamous cells
without areas with NK SCC morphology (Fig. 2). Hybrid
SCC showed nonkeratinizing morphology but with areas
of squamous maturation (Fig. 3). Discrepant cases were
collectively arbitrated around a multi-headed microscope
Fig. 3 Histologic features of
hybrid SCC (H&E stained
sections). a Low-power image
(9200) showing keratinizing
SCC on the left and adjacent
nonkeratinizing SCC on the
right. b High-power image
(9400) showing predominately
ovoid to spindled,
hyperchromatic cells. Focally,
the cells have eosinophilic
(‘‘mature’’) cytoplasm and
distinct cell borders
188 Head and Neck Pathol (2009) 3:186–194by all three study pathologists and placed in a single
category.
Comorbidity Score
The Adult Comorbidity Evaluation (ACE-27) was used to a
calculated comorbidity index [25]. The ACE-27 grades
speciﬁc diseases and conditions into one of three groups,
Grade 1, Grade 2, or Grade 3, according to the severity of
organ decompensation and prognostic impact. An Overall
Comorbidity Score, None, Mild, Moderate,o rSevere,i s
assigned based on the highest ranked single ailment. In the
cases where two or more Grade 2 ailments occur in dif-
ferent organ systems or disease groupings, the Overall
Comorbidity Score is designated as Severe.
In Situ Hybridization for HPV
In Situ Hybridization (ISH) was performed on formalin-
ﬁxed, parafﬁn embedded, 4 lm tissue sections using ISH I
View Blue Plus Detection Kit (Ventana Medical System,
Inc., Tucson, AZ) according to the manufacturer’s
instructions. The probes used hybridized with the high risk
HPV (HR HPV) genotypes including types 16, 18, 33, 35,
45, 51, 52 56, and 66. Ventana Red Counterstain II
(Ventana Medical System, Inc., Tuscon, AZ) was used.
Positive staining was identiﬁed as blue nuclear dots. Any
deﬁnitive nuclear staining in the tumor cells was consid-
ered positive. Cases were classiﬁed in a binary manner as
either positive or negative.
Immunohistochemistry for p16
Immunoperoxidase staining was done on formalin-ﬁxed
parafﬁn embedded, 4 lm tissue sections using the DAKO
LSAB2 horseradish peroxidase system (DAKO Corp.,
Carpentaria, CA) following the manufacturer’s instruc-
tions. Antigen retrieval was done by microwave heating for
10 min in 10 mM citrate buffer (pH 6.0); a p16 monoclonal
antibody (1:40 dilution) was used (Novocastra Labs Ltd.,
UK). Cases were classiﬁed in a binary manner as either
positive (any cells with nuclear and cytoplasmic staining)
or negative.
Statistics
Fisher’s exact test and Student’s t-test for unpaired data
were used to test differences in clinical characteristics,
including comorbidity, as well as HR HPV and p16 results
betweenhistologic groups.Log-rank tests for the equality of
survivor functions and Cox-proportional hazards regression
analysis were used to test differences in survivorship
between groups. A P value of \0.05 was considered sta-
tistically signiﬁcant.
Results
A total of 118 cases of SCC of the oropharynx were
classiﬁed: 55 (46.6%) as NK SCC, 29 (24.6%) as K SCC,
and 34 (28.8%) as hybrid SCC. Clinical characteristics by
histologic type are shown in Table 1. All tumors were more
common in males than females, although signiﬁcantly
fewer females were present in the NK SCC group com-
pared to either the K or hybrid SCC group (Fisher’s exact
test, P = 0.018; P = 0.024). Patients with NK SCC were
slightly younger than those with K SCC and had a mean
age of 54.0 compared to 58.8 years (Student’s t-test,
P = 0.0265). Although there were no differences in stage
across histologic types, NK SCC was more likely than K or
hybrid SCC to have lymph node metastases at presentation
(Fisher’s exact test, P = 0.038; P = 0.036, respectively).
Patients with NK SCC were more likely to have received
up front surgery followed by postoperative radiation rather
than deﬁnitive radiation compared to either K or hybrid
SCC (Fisher’s exact test, P = 0.003; P = 0.017), a ﬁnding
that may be due to the tendency of NK SCC to present as
lymph node metastases with an occult primary tumor that is
usually only detected operatively in the search of a primary
site. One-third (33.9%) of patients also received chemo-
therapy, but there were no differences by histological type
(Fisher’s exact test). Chemotherapy consisted of cisplatin
and/or carboplatin/paclitaxel. Seven patients also received
5-ﬂuorouracil and one patient, docetaxil.
Of the 118 cases, 89 had formalin-ﬁxed parafﬁn
embedded tissue available for HPV testing and p16
immunohistochemistry. Both NK SCC and hybrid SCC
were much more likely to be HR HPV positive than K SCC
(Fisher’s exact test, NK SCC, P\0.001; hybrid SCC,
P = 0.003; Table 2). Both NK SCC and hybrid SCC were
also much more likely to be p16 positive than K SCC
(Fisher’s exact test, NK SCC, P\0.001; hybrid SCC,
P = 0.002, respectively; Table 2). All NK SCCs were p16
positive and 69% were HR HPV positive. Hybrid SCCs
were also frequently p16 and HR HPV positive (81.8 and
45.5%, respectively). In contrast, only 36% of K SCCs
were p16 positive and 8% HR HPV positive. While HR
HPV-ISH staining varied from focal to diffuse, p16 stain-
ing was strong, both nuclear and cytoplasmic, in all cases
and diffuse in the majority (87%) of the cases. Examples of
HR HPV and p16 positive and negative tumors are shown
in Fig. 4.
In all patients, overall survival was 69.3% (61/88) at
3 years. Overall survival was signiﬁcantly better for
patients with tumors classiﬁed as NK SCC or hybrid SCC
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tions, P = 0.0002; P = 0.0105, respectively). Speciﬁcally,
83.3% (30/36) of patients with NK SCC and 73.1% (19/26)
of patients with hybrid SCC tumors were alive at 3 years
compared to 46.2% (12/26) of patients with K SCC tumors.
When survival analysis was then adjusted for age of the
Table 1 Clinical Characteristics of Patients with Oropharyngeal Carcinoma by Histologic Type, Fisher’s exact test and t-test
Histologic type (#) K SCC (29) NK SCC (55) Hybrid SCC (34) Total (118)
Age (Mean ± SD) 58.8 (±9.2) 54.0 (±8.4) 57.1 (±8.4) 56.1 (±9.5)
P value – 0.0265 NS
Sex (%)
Male 23 (79.3) 53 (96.4) 27 (79.4) 103 (87.3)
Female 6 (20.7) 2 (3.6) 7 (20.6) 15 (12.7)
P value 0.018 – 0.024
Smoker (%)
Yes 17 (58.6) 30 (54.5) 17 (50.0) 64 (54.2)
No 3 (10.3) 10 (18.2) 6 (17.6) 19 (16.1)
Unknown 9 (31.0) 15 (27.3) 11 (32.4) 35 (29.7)
P value – NS NS
Stage (%)
II 5 (17.2) 2 (3.6) 1 (2.9) 8 (6.8)
III 6 (20.7) 11 (20.0) 6 (17.6) 23 (19.5)
IVA 17 (58.6) 40 (72.7) 23 (67.6) 80 (67.8)
IVB 1 (3.4) 2 (3.6) 4 (11.8) 7 (5.9)
P value – NS NS
Lymph node metastases (%)
Yes 11 (37.9) 39 (70.9) 16 (47.1) 66 (55.9)
No 12 (41.4) 14 (25.5) 16 (47.1) 42 (35.6)
Unknown 6 (20.7) 2 (3.6) 2 (5.8) 10 (8.5)
P value 0.038 – 0.036
IMRT (%)
Deﬁnitive 14 (48.3) 8 (14.5) 12 (35.3) 34 (28.8)
Post-operative 14 (48.3) 46 (83.6) 20 (58.8) 80 (67.8)
Both 1 (3.4) 1 (1.8) 2 (5.9) 4 (3.4)
P value P = 0.003 – P = 0.017
Chemotherapy (%)
Yes 11 (37.9) 18 (32.7) 11 (32.4) 40 (33.9)
No 18 (62.1) 37 (67.3) 23 (67.6) 78 (66.1)
P value – NS NS
K SCC keratinizing squamous cell carcinoma, NK SCC nonkeratinizing squamous cell carcinoma, Hybrid SCC hybrid squamous cell carcinoma,
IMRT intensity-modulated radiation therapy, NS not signiﬁcant
Table 2 HR HPV-ISH and p16 Status by Histologic Type, Fisher’s exact test
Histologic Type K SCC (25) NK SCC (42) Hybrid SCC (22) Total (89)
HR HPV-ISH (%) 2 (8%) 29 (69%) 10 (45.5%) 41 (46.1%)
P value – \0.001 0.003
p16 IHC (%) 9 (36%) 42 (100%) 18 (81.8%) 69 (77.5%)
P value – \0.001 0.002
K SCC Keratinizing squamous cell carcinoma, NK SCC nonkeratinizing squamous cell carcinoma, Hybrid SCC hybrid squamous cell carcinoma,
HR HPV-ISH high-risk human papilloma virus—in situ hybridization, IHC immunohistochemistry
190 Head and Neck Pathol (2009) 3:186–194patients and for the type of primary therapy, surgery or
deﬁnitive radiation, the overall survival of NK and hybrid
SCC compared to K SCC remained signiﬁcantly better
(Cox-proportional hazards regression analysis, P = 0.001;
P = 0.006, respectively; Fig. 5).
Disease-speciﬁc survival was also better for patients
with NK SCC compared to K SCC (log-rank test for
equality of survivor functions, P = 0.0142; Fig. 6). After
adjusting for age of the patients and for the type of primary
therapy, surgery or deﬁnitive radiation, the disease-speciﬁc
survival of NK SCC was no longer signiﬁcantly better than
K SCC (Cox-proportional hazards regression analysis,
P = 0.106), although there was still a trend. While there
were no signiﬁcant differences in disease-speciﬁc survival
between hybrid SCC and either K SCC or NK SCC, the
disease-speciﬁc survival of hybrid SCC appeared to be
intermediate (Fig. 6).
The possibility that patient comorbidity may have
inﬂuenced survival was also considered. The Adult
Comorbidity Evaluation (ACE-27), a 27-item comorbidity
index for use with cancer patients, was used to calculate a
comorbidity index for the patients in the study [25].
Comorbidity information was available for all but 7
patients (6 with NK SCC and 1 with K SCC). However,
Fig. 4 Examples of HR HPV-
ISH and p16
immunohistochemistry results.
a HR HPV positive (blue
nuclear dots) tumor by ISH
(9600). b HR HPV negative
tumor by ISH (9600). c p16
positive tumor by
immunohistochemistry showing
strong nuclear and cytoplasmic
staining (9400). d p16 negative
tumor by
immunohistochemistry (9400)
Fig. 5 Kaplan–Meier curve of overall survival in patients by
histologic type (Cox-proportional hazards regression analysis). P
values are adjusted for age and surgical versus nonsurgical
management
Fig. 6 Kaplan–Meier curve of disease-speciﬁc survival in patients by
histologic type (log-rank tests for the equality of survivor functions).
P values are unadjusted
Head and Neck Pathol (2009) 3:186–194 191there were no differences in comorbidity scores between
the histologic types (Fisher’s exact test).
Finally, we examined survival within the NK SCC
group. Since all NK SCC cases were p16 positive but only
69% were HR HPV positive, we evaluated whether or not
there was a signiﬁcant survival difference between those
that were HR HPV positive and those that were negative.
We found no difference in either overall or disease-speciﬁc
survival (log-rank test for equality of survivor functions,
P = 0.57 and P = 0.88, respectively), although the num-
ber of patients in each group was small: 29 HPV-negative
NK SCC and 13 HPV-negative NK SCC.
Discussion
HPV infection occurs much more frequently in oropha-
ryngeal SCC than in SCC of other head and neck sites. A
meta-analysis of HPV in tonsillar carcinomas by Syrjanen
et al. [26] showed a positivity rate of 51% at this site. This is
in contrast to other head and neck sites where the HPV
prevalence has been reported to average 20–25% [27].
Evidence suggests that HPV is not a bystander in the oro-
pharynx but in fact drives tumor development there [5].
Furthermore, recent studies strongly suggest that HPV-
driven oropharyngeal SCC is a distinct molecular, patho-
logic, and clinical disease entity [1–9, 14, 20, 21, 28]. This
is not nearly as clear for HPV-positive SCC from other head
and neck sites such as the larynx, hypopharynx, and oral
cavity, where HPV may be present but is not necessarily
promoting tumor development or ‘‘driving’’ its progression.
In nonkeratinizing SCC of the nasal cavity and paranasal
sinuses, however, HPV is an important factor [29].
HPV-positive and negative SCCs of the head and neck
appear to have different molecular origins. HPV-negative
SCCs are characterized by gross chromosomal deletions,
while HPV-positive tumors show only occasional chro-
mosomal loss [17]. This observation provides circumstan-
tial evidence for the etiologic role of HPV in virus-
harboring tumors, since tumors driven by viral infection
and virus-induced signaling pathways theoretically do not
require as many additional mutations in order for malignant
transformation to occur.
HPV-positive SCC is also characterized by a distinct
molecular proﬁle. Speciﬁcally, HPV-positive SCC typically
overexpresses the tumor suppressor p16, lacks p53 muta-
tions, and is less likely to show EGFR ampliﬁcation [5, 18,
19, 23, 30]. In particular, the overexpression of p16 has
emerged as an important biomarker of HPV positivity in
SCC. Detection of p16 expression by immunohistochem-
istry approaches 100% in HPV-positive oropharyngeal
carcinomas in some studies [5, 18]. While other mecha-
nisms may coexist, it is thought that HPV oncoprotein
E7-mediated inactivation of phosphorylated retinoblastoma
protein leads to a loss of inhibition of p16 transcription with
its subsequent overexpression. p16 overexpression is also
observed in HPV-related cervical SCC [31]. In contrast, p16
is usually inactivated in HPV-negative SCC of the head and
neck, leading to minimal, if any, detectable protein by
immunohistochemistry [5, 18].
Many authors have also noted that HPV-positive oro-
pharyngeal carcinomas have distinct histologic features.
Although the molecular mechanism for the divergent
growth pattern is unknown [2, 20, 21, 28], they are likely
related to the viral oncogenic process. The histologic fea-
tures have been variably described as ‘‘poorly differenti-
ated’’ or ‘‘basaloid’’ [2, 32]. However, the use of these
terms may be misleading, as HPV-negative SCCs may be
poorly differentiated and basaloid SCC is a deﬁned subtype
that is morphologically distinct and, in contrast to HPV-
positive SCC, is associated with an aggressive clinical
course [24, 33]. We therefore prefer the term nonkerati-
nizing squamous cell carcinoma to describe HPV-related
squamous cell carcinoma of the oropharynx.
El-Mofty et al. [20, 21] previously described the speciﬁc
histologic features that characterize HPV-positive oropha-
ryngeal SCCs, noting most to be nonkeratinizing tumors
composed of monomorphic, ovoid and spindle-shaped
hyperchromatic cells with indistinct cell borders forming
sheets, nests and cords and demonstrating frequent mitoses,
apoptosis and comedo-type necrosis. Oropharyngeal SCC
with the described features was strongly correlated with
p16 expression and the presence of HR HPV DNA. In a
subsequent study, El-Mofty et al. [22] showed that the
nonkeratinizing histology in neck lymph node metastases is
associated both with HPV positivity by in situ hybridiza-
tion and very strongly with the primary site of origin being
in the oropharynx. Furthermore, a hybrid histologic group
was described which showed some squamous maturation
that also appeared to be HPV-related [22].
We have currently used the same histologic features to
classify SCC of the oropharynx and conﬁrmed the strong
HPV-association of the nonkeratinizing type both by ISH
for HR HPV subtypes and by p16 immunohistochemistry.
Speciﬁcally, we classiﬁed tumors into three groups: non-
keratinizing squamous cell carcinoma, keratinizing squa-
mous cell carcinoma, and those with overlapping features
(hybrid squamous cell carcinoma). In our study, NK SCC
was strongly associated with HR HPV and p16 positivity
(69 and 100%, respectively) compared to K SCC (8 and
36%, respectively). Hybrid SCC was an intermediate group
with 45.5% HR HPV and 81.8% p16 positivity. The dis-
crepancy between HR HPV positivity by ISH and p16
positivity by immunohistochemistry may be due to imper-
fect sensitivity of HR HPV-ISH or, alternatively, viral
shedding at later stages of tumor progression.
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and neck and, in particular, of the oropharynx is associated
with better overall and disease-speciﬁc patient survival
than HPV-negative SCC [1, 2, 4, 6, 7, 9]. Better outcome
has been demonstrated both in patients treated with surgery
or with radiation therapy [6, 7, 34]. However, clear char-
acterization of the histologic features is not widely known,
and an association between SCC histology alone and
patient outcome has not been previously demonstrated.
In the present study, we have shown that histologic
features can be used to classify oropharyngeal carcinomas
into outcome related groups. NK SCC was associated with
better overall and disease-speciﬁc survival compared to K
SCC. While hybrid SCC was also associated with better
overall survival compared to K SCC, the disease-speciﬁc
survival appeared to be intermediate. When survival anal-
ysis was adjusted for age and type of primary management,
the differences in overall survival remained. However, the
difference in disease-speciﬁc survival between NK and K
SCC was no longer signiﬁcant, although there was still a
trend (P = 0.106). This may be in part due to the low
number of disease-speciﬁc deaths in any of the histologic
groups. Seven of 22 patients with K SCC versus 4 of 51
patients with NK SCC died of disease. A prospective study
including a larger sample size may resolve this ﬁnding. It is
important to note that the survival advantage of NK SCC
and hybrid SCC can not be attributed to better overall
health of these patients since signiﬁcant co-morbidity dif-
ferences were not detected among the groups.
In addition, within the NK SCC group, we found no
difference in survival between those that are HR HPV-
positive and those that are negative. While this ﬁnding will
need conﬁrmation in a larger cohort of patients, it may
reﬂect the imperfect sensitivity of HR HPV-ISH or shed-
ding of virus at later stages of tumor progression. It also
supports the concept that NK SCC histology, which is
associated with p16 positivity in 100% of cases, may be
more important in prediction of outcome than actual HPV
status.
In summary, we have shown that histologic classiﬁca-
tion of squamous cell carcinoma of the oropharynx is
clinically useful. It identiﬁes a group of tumors (NK SCC)
for which HPV-association is essentially implied and
which have better patient survival. Hybrid and K SCC
histology indicate sequentially lesser frequencies of HPV
positivity. It is likely that hybrid SCC also represents an
intermediate prognostic group between NK and K SCC.
The proposed classiﬁcation of oropharyngeal carcinomas
into nonkeratinizing, hybrid, and keratinizing squamous
cell carcinoma parallels the current World Health Organi-
zation classiﬁcation of nasopharyngeal carcinomas into
nonkeratinizing and keratinizing types with the former
being strongly associated with Epstein-Barr virus [35]. We
believe that, as in the case of nasopharyngeal carcinomas,
the diagnosis of virally related oropharyngeal carcinomas
can be based, to a large extent, on their morphologic fea-
tures with adjuvant HPV-ISH and p16 immunostaining in
selected cases, speciﬁcally those with hybrid or keratinizing
morphology. For tumors with NK SCC morphology, adju-
vant testing is not necessary as 100% are p16 positive and
HR HPV-ISH status does not appear to further stratify
tumor behavior. It is hoped that increased familiarity with
the histologic features of oropharyngeal carcinomas may
lead to the use of simple light microscopic examination as
an integral part of the algorithm for the detection of HPV-
related carcinomas.
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